[Federal Register Volume 77, Number 191 (Tuesday, October 2, 2012)]
[Notices]
[Page 60144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-24184]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Morton Grove Pharmaceuticals

    Pursuant to 1301.33(a), Title 21 of the Code of Federal Regulations 
(CFR), this is notice that on July 12, 2012, Morton Grove 
Pharmaceuticals, 6451 Main Street, Morton Grove, Illinois 60053-2633, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid 
(2010), a basic class of controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance 
for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 3, 2012.

    Dated: September 25, 2012.
Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-24184 Filed 10-1-12; 8:45 am]
BILLING CODE 4410-09-P